Flexeril and Spitting up - a phase IV clinical study of FDA data
Summary:
We study 38,307 people who take Flexeril (cyclobenzaprine hydrochloride) or have Spitting up. No report of Spitting up is found in people who take Flexeril.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
What is Flexeril?
Flexeril has active ingredients of cyclobenzaprine hydrochloride. It is often used in muscle spasms. eHealthMe is studying from 38,304 Flexeril users. Check the latest studies of Flexeril.
What is Spitting Up?
Spitting up: no further information found.
No report is found.
Do you take Flexeril and have Spitting up?
- Check whether Spitting up is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Flexeril:
- Flexeril (38,304 reports)
Spitting up treatments and more:
- Spitting up (3 reports)
How severe was Spitting up and when was it recovered:
Expand to all the drugs that have ingredients of cyclobenzaprine hydrochloride:
Browse all side effects of Flexeril:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Spitting up:
Browse all the conditions that are associated with Spitting up:
Drugs similar to Flexeril and Spitting up :
How the study uses the data?
The study uses data from the FDA. It is based on cyclobenzaprine hydrochloride (the active ingredients of Flexeril) and Flexeril (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Kenalog and Marinol - now
- Levocetirizine Hydrochloride vs. Patanase, side effect and effectiveness comparison - 6 seconds ago
- Mobic and Multivitamin drug interactions for women aged 60+ - 12 seconds ago
- Percocet and Benadryl drug interactions for women aged 40-49 - 17 seconds ago
- Drug interactions of Metformin and Zaroxolyn - 36 seconds ago
- How effective is Modafinil for Sleep Apnea? - 36 seconds ago
- Could Synthroid cause Penis Pain? - 40 seconds ago
- Drug interactions of Feraheme and Loraz - 40 seconds ago
- Keflex and Soma drug interactions for women aged 60+ - 52 seconds ago
- Drug interactions of Albuterol Sulfate and Lantus - 58 seconds ago